首页> 美国卫生研究院文献>The Canadian Journal of Hospital Pharmacy >Effect of Misalignment between Hospital and Provincial Formularies on Medication Discrepancies at Discharge: PPITS (Proton Pump Inhibitor Therapeutic Substitution) Study
【2h】

Effect of Misalignment between Hospital and Provincial Formularies on Medication Discrepancies at Discharge: PPITS (Proton Pump Inhibitor Therapeutic Substitution) Study

机译:医院和省级处方药错配对出院时药物差异的影响:PPITS(质子泵抑制剂治疗替代)研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMedication discrepancies may occur on admission, transfer, or discharge from hospital. Therapeutic interchange within a drug class is a common practice in hospitals, and orders for specific proton pump inhibitors (PPIs) are often substituted with the hospital’s formulary PPI through therapeutic interchange protocols. Rabeprazole is the PPI on the formulary of the British Columbia PharmaCare program. However, different PPIs may appear on the formularies of the province’s hospitals. This misalignment and use of therapeutic interchange may lead to increased rates of medication discrepancies at the time of discharge.
机译:背景入院,转院或出院时可能会出现药物差异。在医院内,药物类别内的治疗互换是一种常见的做法,通过治疗互换协议,特定质子泵抑制剂(PPI)的订单通常由医院的处方PPI代替。雷贝拉唑是不列颠哥伦比亚省PharmaCare计划制定的PPI。但是,该省医院的处方中可能会出现不同的PPI。这种未对准和使用治疗性互换可能会导致出院时药物差异率增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号